XNW-14011

N/A

Report date: 2024/06/27 10:40:02
NME

Base Information

Drug NameXNW-14011
Drug Alias NameXNW-14011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12C inhibitors
TargetsKRAS G12C
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEvopoint Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEvopoint Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A